Altria sells cigarettes in the United States. Marlboro is its brand. It is not Philip Morris International: the cigarette abroad is PMI's, and the one at home is Altria's. Volume falls. For years price has offset that decline. That is a history, not a law. A regulator can cut the price, menthol or nicotine.
What is not the cigarette is read separately. There have been investments outside the pack that destroyed value. The figure is in the accounts. This report does not state it. Oral nicotine is a smaller book. A share is not stated here.
The dividend is large in the story and a trap if volume falls by more than price can rise. This report does not state a 7% yield or any other yield.
Sustainable Competitive Advantage
"The advantage is Marlboro already asked for at the American counter and the difficulty a new rival has in advertising. It is not absolute pricing power. The smoker can quit, switch brand or move to another nicotine. The moat narrows if volume falls by more than price, or if the rule bans the product that is sold."
Loading the Vaultflake…
Radar axes
—
Health
—
Moat
—
Growth
—
Value
—
Return
—
Health is the cash of the cigarette minus what has been lost outside it. An odd axis may be saying that investment, not the Marlboro margin. Quality is price against volume. Cigarette growth is negative: what grows, if it grows, is the other nicotine. P/E valuation is read against that volume decline, not against a yield from the short blurb. Shareholder return is the dividend, crossed with what the rule still allows to be sold.
Dividend yield is first in line and the wrong multiple if earnings do not hold. The P/E of a year of price increases is not earnings when the volume decline speeds up. Do not compare it with Philip Morris: one is the United States and the other is the rest, and the products are no longer only the pack. A dash means MO is missing.
Limits of this report
Not advice on MO. Vaultflake does not forecast a rule or a Marlboro share. This is not the figure of a failed investment. Read the filings. A past dividend is not a right. The table is cache, not a live quote.
Questions from this report
What moat does Altria Group have?
The advantage is Marlboro already asked for at the American counter and the difficulty a new rival has in advertising. It is not absolute pricing power. The smoker can quit, switch brand or move to another nicotine. The moat narrows if volume falls by more than price, or if the rule bans the product that is sold.
How do you read the Altria Group radar?
Health is the cash of the cigarette minus what has been lost outside it. An odd axis may be saying that investment, not the Marlboro margin. Quality is price against volume. Cigarette growth is negative: what grows, if it grows, is the other nicotine. P/E valuation is read against that volume decline, not against a yield from the short blurb. Shareholder return is the dividend, crossed with what the rule still allows to be sold.
Which multiples matter for Altria Group?
Dividend yield is first in line and the wrong multiple if earnings do not hold. The P/E of a year of price increases is not earnings when the volume decline speeds up. Do not compare it with Philip Morris: one is the United States and the other is the rest, and the products are no longer only the pack. A dash means MO is missing.
What does this Altria Group analysis leave out?
Not advice on MO. Vaultflake does not forecast a rule or a Marlboro share. This is not the figure of a failed investment. Read the filings. A past dividend is not a right. The table is cache, not a live quote.
Related reports in Consumer Staples · US Cigarettes
